Condition
Chemotherapy Induced Alopecia
Total Trials
6
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 6 trials
Late-Stage Pipeline
17%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
6Total
Not Applicable (2)
Early P 1 (2)
P 1 (1)
P 3 (1)
Trial Status
Not Yet Recruiting3
Recruiting2
Active Not Recruiting1
Clinical Trials (6)
Showing 6 of 6 trials
NCT07397325Phase 1Not Yet RecruitingPrimary
Clinical Study of DA-020 for the Treatment of Chemotherapy Induced Alopecia
NCT07402330Early Phase 1Not Yet RecruitingPrimary
Pharmacokinetic Study of DA-020
NCT07033845Early Phase 1RecruitingPrimary
Pharmacokinetic Study of Topical Phenylephrine
NCT07201389Not ApplicableActive Not Recruiting
CARE (Chemotherapy Alopecia REduction)
NCT06762548Phase 3Not Yet RecruitingPrimary
Clinical Study of DA-007 for the Treatment of Chemotherapy Induced Alopecia
NCT06786078Not ApplicableRecruitingPrimary
The Lily Device Trial
Showing all 6 trials